N-ethyl-2-[3-methyl-7-(morpholine-4-sulfonyl)-4-oxo-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]-N-phenylacetamide
Chemical Structure Depiction of
N-ethyl-2-[3-methyl-7-(morpholine-4-sulfonyl)-4-oxo-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]-N-phenylacetamide
N-ethyl-2-[3-methyl-7-(morpholine-4-sulfonyl)-4-oxo-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]-N-phenylacetamide
Compound characteristics
| Compound ID: | G640-0825 |
| Compound Name: | N-ethyl-2-[3-methyl-7-(morpholine-4-sulfonyl)-4-oxo-3,4-dihydro-1,5-benzothiazepin-5(2H)-yl]-N-phenylacetamide |
| Molecular Weight: | 503.64 |
| Molecular Formula: | C24 H29 N3 O5 S2 |
| Smiles: | CCN(C(CN1C(C(C)CSc2ccc(cc12)S(N1CCOCC1)(=O)=O)=O)=O)c1ccccc1 |
| Stereo: | RACEMIC MIXTURE |
| logP: | 2.872 |
| logD: | 2.872 |
| logSw: | -3.4646 |
| Hydrogen bond acceptors count: | 11 |
| Polar surface area: | 70.383 |
| InChI Key: | WOHACGPZLAXWNG-GOSISDBHSA-N |